Highlights and Quick Summary
- Debt/Assets for the quarter ending March 31, 2022 was 20.03% (a 48.04% increase compared to previous quarter)
- Year-over-year quarterly Debt/Assets increased by 72.38%
- Annual Debt/Assets for 2021 was 13.53% (a -72.06% decrease from previous year)
- Annual Debt/Assets for 2020 was 48.42% (a -68.57% decrease from previous year)
- Annual Debt/Assets for 2019 was 154.08% (a 40.48% increase from previous year)
Visit stockrow.com/NVCN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Debt/Assets of Neovasc Inc.
Most recent Debt/Assetsof NVCN including historical data for past 10 years.Interactive Chart of Debt/Assets of Neovasc Inc.
Neovasc Inc. Debt/Assets for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | 20.03% | – | – | – | – |
| 2021 | 13.53% | 12.52% | 11.62% | 10.86% | 13.53% |
| 2020 | 48.42% | 46.6% | 78.04% | 88.55% | 48.42% |
| 2019 | 145.12% | 113.24% | 81.53% | 69.94% | 154.08% |
| 2018 | 109.68% | 164.08% | 101.28% | 169.86% | 109.68% |
| 2017 | 90.1% | 0.0% | 0.0% | 0.0% | 90.1% |
| 2016 | 0.0% | 0.0% | 157.47% | 0.0% | 0.0% |
| 2015 | 0.0% | 0.0% | 0.0% | 0.16% | 0.0% |
| 2014 | 0.83% | 0.59% | 0.72% | 0.68% | 0.86% |
| 2013 | 3.18% | 2.73% | 2.56% | 3.13% | 3.18% |
| 2012 | 3.18% | 6.18% | 5.63% | 5.38% | 3.18% |
| 2011 | 5.08% | – | – | – | 5.08% |
Business Profile of Neovasc Inc.
Sector: Healthcare
Industry: Medical Devices
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.